Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Cellectis S.A. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +1 vs. Q2 2024
- Shares held
- 9.77M
- −3.49K (0.0%) vs. Q2 2024
- Total value
- $20.9M
- +$2.59M (+14.2%) vs. Q2 2024
- New holders
- 3
- 5 more added
- Sold out
- 2
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 4,617,293 | $9.88M | 0.87% | 00.0% | Unchanged |
| Capital International Investors | 1,848,804 | $3.96M | 0.00% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 1,438,255 | $3.05M | 0.00% | 00.0% | Unchanged |
| Baillie Gifford & Co | 693,939 | $1.49M | 0.00% | −13,691−1.9% | Reduced |
| Principal Financial Group Inc | 411,800 | $881.3K | 0.00% | −25,200−5.8% | Reduced |
| Macquarie Group Ltd | 226,875 | $486.0K | 0.00% | 00.0% | Unchanged |
| KBC Group NV | 163,447 | $347.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 92,372 | $195.8K | 0.00% | +585+0.6% | Added |
| Morgan Stanley | 91,525 | $194.0K | 0.00% | +5,200+6.0% | Added |
| Two Sigma Investments, LP | 33,412 | $70.8K | 0.00% | −6,877−17.1% | Reduced |
| Citadel Advisors LLC | 27,624 | $59.1K | 0.00% | +925+3.5% | Added |
| First Affirmative Financial Network | 21,094 | $44.8K | 0.02% | +21,094 | New |
| BNP Paribas Arbitrage, SA | 18,400 | $39.4K | 0.00% | +1,700+10.2% | Added |
| Baird Financial Group, Inc. | 15,090 | $32.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 13,095 | $28.0K | 0.00% | −2,225−14.5% | Reduced |
| Susquehanna International Group, LLP | 13,010 | $27.8K | 0.00% | +13,010 | New |
| Wells Fargo & Company | 12,090 | $25.6K | 0.00% | −700−5.5% | Reduced |
| Geode Capital Management, LLC | 10,776 | $23.1K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 6,100 | $12.9K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 3,855 | $8.25K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $7.63K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,755 | $5.84K | 0.00% | +2,755 | New |
| Allworth Financial LP | 500 | $1.06K | 0.00% | 00.0% | Unchanged |
| POM Investment Strategies, LLC | 495 | $1.05K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 83 | $178 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 77 | $163 | 0.00% | +75+3,750.0% | Added |
| EverSource Wealth Advisors, LLC | 13 | $28 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |